TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of participants retained in PrEP care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child Patient End of Life Care Module Knowledge Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Thanatophobia Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of symptomatic intracranial hemorrhage (sICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HPV test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smear test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Practice Adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Rating of Satisfaction and Liking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in breath alcohol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saccade inhibition rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acuity Risk Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to recommended cancer treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical trial participation within first 24 months of metastatic breast cancer diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiological response to pre-operative chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical response to pre-operative chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological response to pre-operative chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of biliary tract complications
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Isokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ulcer Surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Use of internal intimate protections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of external intimate protections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in PTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Michigan neuropathy screening instrument
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood pressure mean value of differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure standard deviation of differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Structural connectivity as indicated by fractional anisotropy (FA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Structural connectivity as indicated by mean diffusivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tremor as assessed by score on The Essential Tremor Rating Scale (TETRAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Occurrence of Medically-Attended Adverse Events (MAAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of New-Onset Chronic Medical Conditions (NOCMC)
Endpoint domain: Adverse events/effects
Primary endpoint: MAT retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from Baseline in Integrated Alzheimer's Disease Rating Scale (iADRS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean tenofovir diphosphate concentration levels in dried blood spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined measure of virological suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with changes in physical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with change in Absolute Forced Expiratory Volume in 1 second (FEV1) >10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mandibular Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraarticular synovitis scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of pregnancy outcomes in early pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of pregnancy outcomes during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of pregnancy outcomes after 20 weeks gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of outcomes in neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of outcomes in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Inflammation Marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endorphin Hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Differential tumoral CD8 T-cell infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse event documentation of FMT in advanced HCC
Endpoint domain: Adverse events/effects
Primary endpoint: Number of SGA and LGA infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Motivation as measured by the Brain Injury Rehabilitation Trust Motivation Questionnaire (BMQ-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Laboratory identified pharyngeal gonorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Analgesia as measured using the Cold Pressor Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IBD PRO responses/scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete Cure at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graded Chronic Pain Scale-Revised (GCPS-R)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Short Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: 6-Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Handgrip Strength Test (HGST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of concentration of serum albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of concentration of serum hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speed of functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient's vision assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in time in upright position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of sit-to-stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Momentary Assessment of Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immune therapy response prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peptic ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physician feedback on algorithm performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colonic gas volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absolute Change from Baseline in Forced Vital Capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from Baseline in MG-ADL score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ocular and Systemic Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Requested to Participate in Home-based Saliva-based SARS-CoV-2 Antibody Testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Completed Home-based Salivary Antibody Testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hospitalisation due to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: early toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants who meet the definition of transfusion independence for at least 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Trough FEV1 on Day 85
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in gastric perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of cells per cluster in tissue sample of wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV RNA viral load detection, sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV DNA viral load detection, sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of small volume testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of expired O2 at facemask during preoxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of expired pharyngeal O2 during preoxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change over time in motor function in children 2 years old and younger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change over time in pulmonary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in scores for the pediatric quality of life inventory parent report (PedsQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: feasibility of ctDNA and FDG-PET interim response adapted approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for BEC to recover to stable state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of the cross-sectional antral area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of positive and negative lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ECMO weaning success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Annual Influenza Vaccine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence of Grade ≥2 Adverse Events (AE) or Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Time from ART discontinuation to sustained HIV-1 RNA ≥ 1000 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Adverse drug reaction (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incident Neoplasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incident Diabetes Mellitus type 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lung function changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knowledge of teratogenic risk of REBLOZYL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of pregnancy outcomes evaluation for WCBP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of contraception methods for WCBP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Baseline children's reported anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of physical and emotional well-being reported by children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-Concept
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of anxiety disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Alleviation of Targeted RSV Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Participants With Clinical Remission at Week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Participants With Endoscopic Response at Week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of treatment-related acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of treatment-related late toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with complete success defined as intraocular pressure reduction > 25% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Prolonged hospital length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in 18F-mFBG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ocular adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants achieving at least 20% improvement in ACR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: completely resolution or persistence of small lesion remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response (CR) + very good partial response (VGPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat oxidation (fat burning)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum tolerated dose or recommended phase II dose (RP2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite clinical endpoint (win ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change from baseline in EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion and abundance of bacterial taxa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Serum γ-glutamyl transpeptidase (GGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Serum bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Serum bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Serum aspartate aminotransferase (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Improvement in Conscious Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microbiome intestinal markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rate of gastric mucosal erosion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in global cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants expressing intervention program satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiovascular disease risk assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline in Kidney Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Assessment of disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Global Physical Assessments: severity of physical diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state area under the plasma concentration-time curve (AUCtau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state maximum observed plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Steady-state time to attain the maximum observed plasma concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving ≥4-point improvement in I-NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG of quadriceps muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of dose-limiting toxicities (DLTs) of IDP-023 Monotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-tumor activity by objective response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neurofilament light chain (NFL) blood level evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tolerance of the treatment regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Daily perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily expectation of perceived stress level on the following day
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Nocturnal Sleep Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Percent Sleep Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modena bleeding score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brain Activation to Reward
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life after Self-management intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Interpersonal Reactivity Index (IRI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of malnutrition - overall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Use of CLARE app
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of CLARE chat
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Subject-rated abuse liability
Endpoint domain: Adverse events/effects
Primary endpoint: time to development of DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in Apnea-Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Participants Achieving Pediatric Crohn's Disease Activity Index (PCDAI) Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Endoscopic Response per Simple Endoscopic Score for Crohn's Disease (SES-CD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of Risankizumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of >= grade 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of AEs Leading to Study Drug Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of moderate or severe AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with Clinically Significant Laboratory Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Freezing of Gait Questionnaire (FOG-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of SKAMP-combined scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception (elbow and shoulder)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Strength (elbow and shoulder)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility (shoulder)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance (Speed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kellgren Lawrence Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes